Cargando…

Attenuated ZHX3 expression is predictive of poor outcome for liver cancer: Indication for personalized therapy

The zinc-fingers and homeoboxes (ZHX) family members have been characterized as master regulators in cancer initiation and development. The present study performed in silico data-mining with publicly available datasets and immunohistochemistry to assess the expression status of ZHX factors and the c...

Descripción completa

Detalles Bibliográficos
Autores principales:	You, Yanjie, Hu, Fangrui, Hu, Shengjuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185145/ https://www.ncbi.nlm.nih.gov/pubmed/35720472 http://dx.doi.org/10.3892/ol.2022.13345

Ejemplares similares

Attenuated ZHX3 expression serves as a potential biomarker that predicts poor clinical outcomes in breast cancer patients
por: You, Yanjie, et al.
Publicado: (2019)

Low expression of ZHX1 and ZHX2 impacts on the prognosis of chronic lymphocytic leukemia
por: Maciel, Natália Ioseph Gladistone, et al.
Publicado: (2021)

Low expression of ZHX3 is associated with progression and poor prognosis in colorectal cancer
por: Cai, Zhai, et al.
Publicado: (2023)

Upregulation of ZHX2 predicts poor prognosis and is correlated with immune infiltration in gastric cancer
por: Cheng, Anqi, et al.
Publicado: (2021)

ZHX2 in health and disease
por: Li, Na, et al.
Publicado: (2022)

ZHX2 emerges as a negative regulator of mitochondrial oxidative phosphorylation during acute liver injury
por: Zhang, Yankun, et al.
Publicado: (2023)

ZHX1 Promotes the Proliferation, Migration and Invasion of Cholangiocarcinoma Cells
por: Kwon, Ryuk-Jun, et al.
Publicado: (2016)

ZHX2 is a repressor of α-fetoprotein expression in human hepatoma cell lines
por: Shen, H, et al.
Publicado: (2008)

USP13 promotes deubiquitination of ZHX2 and tumorigenesis in kidney cancer
por: Xie, Haibiao, et al.
Publicado: (2022)

ZHX2 deficiency enriches hybrid MET cells through regulating E-cadherin expression
por: He, Yan, et al.
Publicado: (2023)

Loss of the transcription repressor ZHX3 induces senescence-associated gene expression and mitochondrial-nucleolar activation
por: Igata, Tomoka, et al.
Publicado: (2022)

Transcription factor Zhx2 restricts NK cell maturation and suppresses their antitumor immunity
por: Tan, Siyu, et al.
Publicado: (2021)

ZHX2 enhances the cytotoxicity of chemotherapeutic drugs in liver tumor cells by repressing MDR1 via interfering with NF-YA
por: Ma, Hongxin, et al.
Publicado: (2014)

ZHX2 inhibits thyroid cancer metastasis through transcriptional inhibition of S100A14
por: Zhang, Yankun, et al.
Publicado: (2022)

ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancer
por: Fang, Wentong, et al.
Publicado: (2021)

Zhx2 maintains islet β-cell mass and function by transcriptionally regulating Pax6
por: Ding, Lu, et al.
Publicado: (2023)

ZHX1 Inhibits Gastric Cancer Cell Growth through Inducing Cell-Cycle Arrest and Apoptosis
por: Ma, Xingjie, et al.
Publicado: (2016)

Novel structural features in two ZHX homeodomains derived from a systematic study of single and multiple domains
por: Bird, Louise E, et al.
Publicado: (2010)

Tumor suppressor ZHX2 inhibits NAFLD–HCC progression via blocking LPL-mediated lipid uptake
por: Wu, Zhuanchang, et al.
Publicado: (2019)

ZHX2 mediates proteasome inhibitor resistance via regulating nuclear translocation of NF‐κB in multiple myeloma
por: Jiang, Jifeng, et al.
Publicado: (2020)

Novel VHL substrate targets SFMBT1 and ZHX2 may be important prognostic predictors in patients with ccRCC
por: Chen, Yufeng, et al.
Publicado: (2021)

Linc00511 Indicates A Poor Prognosis Of Liver Hepatocellular Carcinoma
por: Hu, Pingan, et al.
Publicado: (2019)

Blocking lncRNA MALAT1/miR-199a/ZHX1 Axis Inhibits Glioblastoma Proliferation and Progression
por: Liao, Keman, et al.
Publicado: (2019)

ZHX3 promotes the progression of urothelial carcinoma of the bladder via repressing of RGS2 and is a novel substrate of TRIM21
por: Deng, Minhua, et al.
Publicado: (2021)

Cooperative regulation of Zhx1 and hnRNPA1 drives the cardiac progenitor-specific transcriptional activation during cardiomyocyte differentiation
por: Chen, Yang, et al.
Publicado: (2023)

High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma
por: Hiyama, E, et al.
Publicado: (2004)

Low STYK1 expression indicates poor prognosis in gastric cancer
por: Fang, Jian, et al.
Publicado: (2018)

High USP22 expression indicates poor prognosis in hepatocellular carcinoma
por: Tang, Bo, et al.
Publicado: (2015)

High expression of DARS2 indicates poor prognosis in lung adenocarcinoma
por: Jiang, Yingfeng, et al.
Publicado: (2022)

Arginase II Expressed in Cancer-Associated Fibroblasts Indicates Tissue Hypoxia and Predicts Poor Outcome in Patients with Pancreatic Cancer
por: Ino, Yoshinori, et al.
Publicado: (2013)

ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation
por: Lin, Qinghai, et al.
Publicado: (2020)

LncRNA LINC01140 Inhibits Glioma Cell Migration and Invasion via Modulation of miR-199a-3p/ZHX1 Axis
por: Xin, Yanchao, et al.
Publicado: (2020)

PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy
por: Huang, Yi-Teng, et al.
Publicado: (2013)

Meta-analysis indicating that high ALCAM expression predicts poor prognosis in colorectal cancer
por: Zhang, Yeqing, et al.
Publicado: (2017)

Elevated FKBP52 expression indicates a poor outcome in patients with breast cancer
por: Hong, Chaoqun, et al.
Publicado: (2017)

Prediction of Poor Outcome in Patients with Acute Liver Failure—Systematic Review of Prediction Models
por: Wlodzimirow, Kama A., et al.
Publicado: (2012)

Low Platelet to White Blood Cell Ratio Indicates Poor Prognosis for Acute-On-Chronic Liver Failure
por: Jie, Yusheng, et al.
Publicado: (2018)

Increased expression of Cyclin F in liver cancer predicts poor prognosis: A study based on TCGA database
por: Zelong, Yang, et al.
Publicado: (2021)

ZHX2 drives cell growth and migration via activating MEK/ERK signal and induces Sunitinib resistance by regulating the autophagy in clear cell Renal Cell Carcinoma
por: Zhu, Liangsong, et al.
Publicado: (2020)

HNRNPD interacts with ZHX2 regulating the vasculogenic mimicry formation of glioma cells via linc00707/miR-651-3p/SP2 axis
por: Yu, Sifei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lf6pantmbjpd52icguh6q4jpa6